Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
2.010
+0.760 (60.80%)
At close: Jun 27, 2025, 4:00 PM
1.740
-0.270 (-13.43%)
After-hours: Jun 27, 2025, 7:59 PM EDT

Autonomix Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22
Selling, General & Admin
6.565.251.2513.59
Research & Development
4.732.230.750
Other Operating Expenses
0.3---
Operating Expenses
11.597.471.9913.59
Operating Income
-11.59-7.47-1.99-13.59
Interest Expense
-0.18-0.08--0.22
Interest & Investment Income
0.350.13--
Other Non Operating Income (Expenses)
--8-0.31
EBT Excluding Unusual Items
-11.41-15.43-1.99-13.5
Other Unusual Items
---0.17
Pretax Income
-11.41-15.43-1.99-13.33
Net Income
-11.41-15.43-1.99-13.33
Preferred Dividends & Other Adjustments
----0.49
Net Income to Common
-11.41-15.43-1.99-12.84
Shares Outstanding (Basic)
2110
Shares Outstanding (Diluted)
2110
Shares Change (YoY)
69.73%73.12%480.20%-
EPS (Basic)
-6.46-14.82-3.31-123.94
EPS (Diluted)
-6.46-14.82-3.31-123.94
Free Cash Flow
-8.27-6.67-1.85-0.39
Free Cash Flow Per Share
-4.68-6.41-3.08-3.74
EBITDA
-11.41-7.39--
D&A For EBITDA
0.180.08--
EBIT
-11.59-7.47-1.99-13.59
Advertising Expenses
-1.8--
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q